The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,4-dichloro-2-(2-methylprop-1-enyl)-1-(piperidin-3-yl)-1H-pyrrolo[2,3-b]pyridine-6-carboxamide ID: ALA4071926
PubChem CID: 137638981
Max Phase: Preclinical
Molecular Formula: C17H20Cl2N4O
Molecular Weight: 367.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)=Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1C1CCCNC1
Standard InChI: InChI=1S/C17H20Cl2N4O/c1-9(2)6-13-15(19)14-11(18)7-12(16(20)24)22-17(14)23(13)10-4-3-5-21-8-10/h6-7,10,21H,3-5,8H2,1-2H3,(H2,20,24)
Standard InChI Key: WVOATLASLUXFNF-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.6471 -27.1117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6459 -27.9313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3540 -28.3402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3522 -26.7029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0608 -27.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0656 -27.9267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8456 -28.1752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3230 -27.5101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8379 -26.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9379 -28.3393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2305 -27.9301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9372 -29.1565 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3497 -25.8857 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.1026 -28.9509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0858 -26.0720 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.5570 -29.5568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8111 -30.3297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6108 -30.4992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1562 -29.8893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9018 -29.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1401 -27.5052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5446 -26.7951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3617 -26.7903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1318 -26.0899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
10 11 2 0
10 12 1 0
4 13 1 0
7 14 1 0
9 15 1 0
14 16 1 0
14 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
8 21 1 0
21 22 2 0
22 23 1 0
22 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.28Molecular Weight (Monoisotopic): 366.1014AlogP: 3.79#Rotatable Bonds: 3Polar Surface Area: 72.94Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.00CX LogP: 3.28CX LogD: 0.77Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.87Np Likeness Score: -0.42
References 1. Barberis C, Moorcroft N, Pribish J, Tserlin E, Gross A, Czekaj M, Barrague M, Erdman P, Majid T, Batchelor J, Levit M, Hebert A, Shen L, Moreno-Mazza S, Wang A.. (2017) Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - Part II., 27 (20): [PMID:28927793 ] [10.1016/j.bmcl.2017.08.068 ]